A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
Phase of Trial: Phase II/III
Latest Information Update: 27 May 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Interferon alpha
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 20 Sep 2011 Status changed from active, no longer recruiting to completed.
- 28 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 15 May 2007 Status changed from initiated to recruiting